Grounded in patient biology and clinical data
HCMI, a decade-long international collaboration, represents one of the world's most extensive and diverse collections of next-generation cancer models, each paired with rich clinical and genomic datasets, including key patient and disease characteristics. Available exclusively through ATCC, these models undergo standardized characterization, extensive data annotation, rigorous authentication, and quality-controlled biobanking, providing researchers with well-defined, ready-to-use, and highly characterized resources for translational cancer research.
Explore HCMI models
Browse patient-derived HCMI models from ATCC, including organoids and non-organoid systems, each authenticated and accompanied by clinical and genomic annotations.
How to use the HCMI Searchable Catalog
Before ordering, explore available genomic and clinical data for HCMI models through the searchable catalog. Filter by diagnosis, gene alterations, clinical stage, patient demographics, and model characteristics to select models that align with your research and improve predictive relevance. Once you’ve identified the right models, return to ATCC to complete your order.
